UREMIC PRURITUS
Clinical trials for UREMIC PRURITUS explained in plain language.
Never miss a new study
Get alerted when new UREMIC PRURITUS trials appear
Sign up with your email to follow new studies for UREMIC PRURITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets debilitating itch for kidney patients
Symptom relief CompletedThis study tested whether a drug called difelikefalin could safely reduce the intensity of severe itching in Chinese adults receiving hemodialysis for kidney failure. 260 participants were randomly assigned to receive either the drug or a placebo (inactive substance) three times …
Matched conditions: UREMIC PRURITUS
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Symptom relief
Last updated Apr 02, 2026 08:45 UTC
-
New drug tested to relieve debilitating itch for dialysis patients
Symptom relief CompletedThis study tested whether an investigational drug called MR13A9 could reduce severe itching in people receiving hemodialysis for kidney disease. In the first part, 178 participants were randomly assigned to receive either MR13A9 or a placebo (a dummy treatment) for 4 weeks to see…
Matched conditions: UREMIC PRURITUS
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Mar 18, 2026 14:41 UTC
-
New drug tested to relieve debilitating itch for dialysis patients
Symptom relief CompletedThis study tested an investigational drug called MR13A9 to see if it could safely reduce severe itching in people receiving hemodialysis for kidney disease. It involved 247 Japanese patients who experienced significant itch despite treatment. Researchers compared different doses …
Matched conditions: UREMIC PRURITUS
Phase: PHASE2 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Mar 11, 2026 14:54 UTC